美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

LB Pharmaceuticals Inc

23.82

-0.0400-0.17%

盤後：23.820.00000.00%17:43 EST

成交量：26.38萬

成交額：629.02萬

市值：6.81億

市盈率：-32.05

高：24.53

開：24.03

低：23.17

收：23.86

52周最高：24.95

52周最低：13.36

股本：2,860.57萬

流通股本：1,900.00萬

量比：1.32

換手率：1.39%

股息：- -

股息率：- -

每股收益(TTM):-0.7433

每股收益(LYR):-250.6146

淨資產收益率：--

總資產收益率：--

市淨率：2.20

市盈率(LYR):-0.10

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

LB製藥宣佈完成1億美元私募配售

Lb Pharmaceuticals Inc盤中異動臨近午盤股價大跌5.21%

LB Pharmaceuticals啓動雙相抑鬱症II期Illuminate-1試驗拓展LB-102研發管線

Lb Pharmaceuticals Inc盤中異動早盤急速下挫5.22%報20.27美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LBRX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","market":"US","secType":"STK","nameCN":"LB Pharmaceuticals Inc","latestPrice":23.82,"timestamp":1770411600000,"preClose":23.86,"halted":0,"volume":263835,"hourTrading":{"tag":"盘后","latestPrice":23.82,"preClose":23.82,"latestTime":"17:43 EST","volume":9312,"amount":221811.84,"timestamp":1770417821492,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0016764459346185728,"floatShares":19000000,"shares":28605700,"eps":-0.743267,"marketStatus":"休市中","change":-0.04,"latestTime":"02-06 16:00:00 EST","open":24.03,"high":24.53,"low":23.165,"amount":6290198.40735,"amplitude":0.057209,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.743267,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"listingDate":1757563200000,"exchange":"NASDAQ","adjPreClose":23.86,"preHourTrading":{"tag":"盘前","latestPrice":24.2,"preClose":23.86,"latestTime":"09:27 EST","volume":68,"amount":1640.81994,"timestamp":1770388078620,"change":0.34,"changeRate":0.01425,"amplitude":0.047779},"postHourTrading":{"tag":"盘后","latestPrice":23.82,"preClose":23.82,"latestTime":"17:43 EST","volume":9312,"amount":221811.84,"timestamp":1770417821492,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3233899984021313},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","floatShares":19000000,"roa":"--","roe":"--","lyrEps":-250.614601,"volumeRatio":1.3233899984021313,"shares":28605700,"dividePrice":0,"high":24.53,"amplitude":0.057209,"preClose":23.86,"low":23.165,"week52Low":13.36,"pbRate":"2.20","week52High":24.9499,"institutionHeld":0,"latestPrice":23.82,"eps":-0.743267,"divideRate":0,"volume":263835,"delay":0,"ttmEps":-0.743267,"open":24.03,"prevYearClose":22.26,"prevWeekClose":21.45,"prevMonthClose":21.45,"prevQuarterClose":22.26,"fiveDayClose":21.45,"twentyDayClose":20.8,"sixtyDayClose":14.61},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LBRX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1768021200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LBRX","date":"2026-02-06","current":-32.047703,"percent":0.009804,"low":-32.168769,"twenty":-28.673392,"median":-21.418938,"eighty":-12.137776,"high":-0.410019,"avg":-20.505255,"sd":7.741296,"marketCap":603636573},"quantilePoints":[{"date":"2025-09-12","current":-13.187639,"twenty":-10.632115,"median":-6.798829,"eighty":-2.965543,"marketCap":388099031},{"date":"2025-09-19","current":-12.217088,"twenty":-12.798201,"median":-12.438246,"eighty":-12.070666,"marketCap":359536683},{"date":"2025-09-26","current":-11.40109,"twenty":-12.682283,"median":-12.163705,"eighty":-11.408716,"marketCap":335522685},{"date":"2025-10-03","current":-11.790024,"twenty":-12.394014,"median":-12.03406,"eighty":-11.475827,"marketCap":346968609},{"date":"2025-10-10","current":-11.927294,"twenty":-12.217088,"median":-11.973051,"eighty":-11.471251,"marketCap":351008347},{"date":"2025-10-17","current":-12.506882,"twenty":-12.401641,"median":-12.018808,"eighty":-11.491079,"marketCap":368065019},{"date":"2025-10-24","current":-12.079817,"twenty":-12.247593,"median":-12.026434,"eighty":-11.561239,"marketCap":355496945},{"date":"2025-10-31","current":-12.415368,"twenty":-12.43367,"median":-12.041687,"eighty":-11.652753,"marketCap":365371860},{"date":"2025-11-07","current":-18.511527,"twenty":-12.493155,"median":-12.14464,"eighty":-11.774771,"marketCap":348090759},{"date":"2025-11-14","current":-20.046619,"twenty":-12.715838,"median":-12.201836,"eighty":-11.777822,"marketCap":376956619},{"date":"2025-11-21","current":-21.244034,"twenty":-16.587413,"median":-12.217088,"eighty":-11.811377,"marketCap":399472820},{"date":"2025-11-28","current":-23.934856,"twenty":-18.511527,"median":-12.278098,"eighty":-11.89679,"marketCap":450071024},{"date":"2025-12-05","current":-25.899155,"twenty":-20.625145,"median":-12.354359,"eighty":-11.912042,"marketCap":487007713},{"date":"2025-12-12","current":-27.217658,"twenty":-21.714928,"median":-12.472564,"eighty":-11.927294,"marketCap":511800833},{"date":"2025-12-19","current":-26.50459,"twenty":-23.934856,"median":-12.598395,"eighty":-11.934921,"marketCap":498392309},{"date":"2025-12-26","current":-29.599034,"twenty":-25.317938,"median":-12.735666,"eighty":-11.971526,"marketCap":556580244},{"date":"2026-01-02","current":-29.948841,"twenty":-26.033696,"median":-12.811928,"eighty":-12.003556,"marketCap":563158010},{"date":"2026-01-09","current":-27.984542,"twenty":-26.736001,"median":-17.717835,"eighty":-12.027959,"marketCap":526221321},{"date":"2026-01-16","current":-28.76488,"twenty":-26.943194,"median":-18.511527,"eighty":-12.038636,"marketCap":540894800},{"date":"2026-01-23","current":-31.724783,"twenty":-27.597063,"median":-20.046619,"eighty":-12.056939,"marketCap":596552825},{"date":"2026-01-30","current":-28.482344,"twenty":-28.30475,"median":-20.93459,"eighty":-12.092019,"marketCap":535581989},{"date":"2026-02-06","current":-32.101498,"twenty":-28.673392,"median":-21.418938,"eighty":-12.137776,"marketCap":603636573}],"updateTime":1770475424650},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LBRX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1124088225","title":"LB製藥宣佈完成1億美元私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1124088225","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124088225?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 21:11","pubTimestamp":1770297074,"startTime":"0","endTime":"0","summary":"纽约，2026年2月5日——专注于开发精神分裂症、双相抑郁等神经精神疾病创新疗法的后期生物制药公司LB Pharmaceuticals Inc今日宣布，已与特定机构投资者签署证券购买协议，通过私募方式发行3,306,571股普通股及可认购最多1,417,107股普通股的预融资权证。普通股发行价为每股21.17美元，预融资权证发行价为每股21.1699美元。在扣除交易费用前，本次私募预计可为公司筹集约1亿美元总收益，交易预计于2026年2月6日左右完成，最终需满足惯例交割条件。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LB","LBRX","BK4233","BK4213"],"gpt_icon":0},{"id":"2609823303","title":"Lb Pharmaceuticals Inc盤中異動 臨近午盤股價大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609823303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609823303?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 00:38","pubTimestamp":1770223120,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日00时38分，Lb Pharmaceuticals Inc股票出现波动，股价大幅下挫5.21%。截至发稿，该股报20.73美元/股，成交量1.5171万股，换手率0.06%，振幅8.18%。Lb Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.37%。Lb Pharmaceuticals Inc公司简介：LB Pharmaceuticals Inc 是一家临床阶段生物制药公司，开发用于治疗精神分裂症、双相抑郁症和其他神经精神疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205003840953fd96e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205003840953fd96e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LBRX"],"gpt_icon":0},{"id":"1167670995","title":"LB Pharmaceuticals啓動雙相抑鬱症II期Illuminate-1試驗 拓展LB-102研發管線","url":"https://stock-news.laohu8.com/highlight/detail?id=1167670995","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167670995?lang=zh_tw&edition=fundamental","pubTime":"2026-01-26 21:02","pubTimestamp":1769432543,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals近日正式启动针对双相抑郁症的II期临床试验Illuminate-1，标志着其核心候选药物LB-102的研发版图实现重要拓展。该试验旨在评估LB-102在双相抑郁患者中的疗效与安全性，为这一难治性精神疾病提供潜在创新疗法。\nIlluminate-1试验的推进不仅深化了LB-102的临床开发路径，更彰显了公司对精神神经疾病治疗领域的战略聚焦。通过阶段性临床试验数据的积累，LB Pharmaceuticals有望进一步验证该药物的治疗潜力，为后续研发决策提供关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","BK4007"],"gpt_icon":0},{"id":"2604391875","title":"Lb Pharmaceuticals Inc盤中異動 早盤急速下挫5.22%報20.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604391875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604391875?lang=zh_tw&edition=fundamental","pubTime":"2026-01-17 00:17","pubTimestamp":1768580279,"startTime":"0","endTime":"0","summary":"北京时间2026年01月17日00时17分，Lb Pharmaceuticals Inc股票出现异动，股价大幅跳水5.22%。截至发稿，该股报20.27美元/股，成交量4.6651万股，换手率0.18%，振幅6.20%。Lb Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.12%。Lb Pharmaceuticals Inc公司简介：LB Pharmaceuticals Inc 是一家临床阶段生物制药公司，开发用于治疗精神分裂症、双相抑郁症和其他神经精神疾病的新型疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117001759953d1c42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117001759953d1c42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LBRX"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LBRX\",params:#limit:6,delay:false,,,undefined,":[]}}